AJUDAR OS OUTROS PERCEBER AS VANTAGENS DA FDA APPROVED OBSTRUCTIVE SLEEP APNEA TREATMENT

Data indicate that the Inspire device reduces sleep apnea by an average of 79% and significantly reduces snoring and daytime sleepiness. In addition to daytime tiredness and irritability, people with sleep apnea are at higher risk for stroke, type 2 diabetes, metabolic syndrome and liver problems.Uvulopalatopharyngoplasty (UPPP) involves reducing t